Chromium picolinate modulates nitric oxide pathways but enhances myocardial peroxynitrite formation in a rat heart during metabolic syndrome modeling
DOI:
https://doi.org/10.15584/ejcem.2026.2.3Keywords:
chromium picolinate, heart, metabolic syndrome, nitric oxide, p38-MAPKAbstract
Introduction and aim. Metabolic syndrome (MetS) is a global non-communicable health burden. Chromium picolinate (CRPIC) as modulator of p38 MAPK cascade may have a potential therapeutic effect on MetS.
The objective of the present study is to evaluate the effects of CRPIC administration on nitric oxide generation and myocardial levels of nitric oxide metabolites in rats under conditions of metabolic syndrome.
Material and methods. The experiment was performed on 24 Wistar rats, which were randomly allocated into four groups (n=6 per group): Group I, the control group; Group II, the metabolic syndrome (MetS) group, in which MetS was induced by providing a 20% fructose solution as the sole source of drinking water for 60 days; Group III, the CRPIC-treated group, receiving CRPIC at a dose of 80 µg/kg; and Group IV, the CRPIC+MetS group, in which CRPIC administration was carried out under conditions of experimentally induced metabolic syndrome. The following biochemical parameters were evaluated: total nitric oxide synthase (NOS) activity, inducible NOS (iNOS) and constitutive NOS (cNOS) activities, arginase activity, nitrite reductase and nitrate reductase activities, as well as the concentrations of nitrites, peroxynitrites, nitrosothiols, and hydrogen sulfide.
Results. Administration of CRPIC under MetS conditions resulted in a 38.2% reduction in NOS activity and a 40.2% decrease in iNOS activity, accompanied by a 48.9% increase in cNOS activity compared with the MetS group. CRPIC treatment also reduced arginase activity by 13.2%. While the activity of nitrate reductase remained unchanged, nitrite reductase activity decreased by 37.0%. Furthermore, CRPIC increased nitrite levels by 95.2% and peroxynitrite concentrations by 35.2%, while the content of nitrosothiols was reduced by 49.1%. H2S levels also decreased by 16.8%.
Conclusion. Administration of CRPIC on the background of metabolic syndrome modeling alleviates enhanced nitric oxide production from the L-arginine-dependent and L-arginine-independent pathways, but increases peroxynitrite compared to the metabolic syndrome group.
Downloads
References
Lushchak VI, Covasa M, Abrat OB, et al. Risks of obesity and diabetes development in the population of the Ivano-Frankivsk region in Ukraine. EXCLI J. 2023;22:1047-1054. doi:10.17179/excli2023-6296
Chandrasekaran P, Weiskirchen R. The Role of Obesity in Type 2 Diabetes Mellitus-An Overview. Int J Mol Sci. 2024;25(3):1882. doi:10.3390/ijms25031882
Sanz RL, Inserra F, García Menéndez S, Mazzei L, Ferder L, Manucha W. Metabolic Syndrome and Cardiac Remodeling Due to Mitochondrial Oxidative Stress Involving Gliflozins and Sirtuins. Curr Hypertens Rep. 2023;25(6):91-106. doi:10.1007/s11906-023-01240-w
Liu J, Aylor KW, Chai W, Barrett EJ, Liu Z. Metformin prevents endothelial oxidative stress and microvascular insulin resistance during obesity development in male rats. Am J Physiol Endocrinol Metab. 2022;322(3):E293-E306. doi:10.1152/ajpendo.00240.2021
Ruan G, Wu F, Shi D, Sun H, Wang F, Xu C. Metformin: update on mechanisms of action on liver diseases. Front Nutr. 2023;10:1327814. doi:10.3389/fnut.2023.1327814
Moradi F, Kooshki F, Nokhostin F, Khoshbaten M, Bazyar H, Pourghassem Gargari B. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial. J Trace Elem Med Biol. 2021;63:126659. doi:10.1016/j.jtemb.2020.126659
Mamikutty N, Thent ZC, Sapri SR, Sahruddin NN, Mohd Yusof MR, Haji Suhaimi F. The establishment of metabolic syndrome model by induction of fructose drinking water in male Wistar rats. Biomed Res Int. 2014;2014:263897. doi:10.1155/2014/263897
Sahin K, Tuzcu M, Orhan C, et al. Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin. Br J Nutr. 2013;110(2):197-205. doi:10.1017/S0007114512004850
Yelins’ka AM, Akimov OYe, Kostenko VO. Role of AP-1 transcriptional factor in development of oxidative and nitrosative stress in periodontal tissues during systemic inflammatory response. Ukr Biochem J. 2019;91(1):80-85. doi:10.15407/ubj91.01.080
Mykytenko A, Akimov O, Yeroshenko G, Neporada K. Phenformin attenuates the oxidative-nitrosative stress in the liver of rats under long-term ethanol administration. Ukr Biochem J. 2024;96(3):22-30. doi:10.15407/ubj96.03.022
El-Kafoury BMA, Bahgat NM, Abdel-Hady EA, Samad AAAE, Shawky MK, Mohamed FA. Impaired metabolic and hepatic functions following subcutaneous lipectomy in adult obese rats. Exp Physiol. 2019;104(11):1661-1677. doi:10.1113/EP087670
Zhang Y, Wang R, Fu X, Song H. Non-insulin-based insulin resistance indexes in predicting severity for coronary artery disease. Diabetol Metab Syndr. 2022;14(1):191. doi:10.1186/s13098-022-00967-x
Andrade N, Rodrigues I, Carmo F, et al. Sustainable Utilization of Coffee Pulp, a By-Product of Coffee Production: Effects on Metabolic Syndrome in Fructose-Fed Rats. Antioxidants (Basel). 2025;14(3):266. doi:10.3390/antiox14030266
Mohammad-Sadeghipour M, Afsharinasab M, Mohamadi M, Mahmoodi M, Falahati-Pour SK, Hajizadeh MR. The Effects of Hydro-Alcoholic Extract of Fenugreek Seeds on the Lipid Profile and Oxidative Stress in Fructose-Fed Rats. J Obes Metab Syndr. 2020;29(3):198-207. doi:10.7570/jomes19051
Geohas J, Daly A, Juturu V, Finch M, Komorowski JR. Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Am J Med Sci. 2007;333(3):145-53. doi:10.1097/MAJ.0b013e318031b3c9
Paiva AN, Lima JG, Medeiros AC, et al. Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study. J Trace Elem Med Biol. 2015;32:66-72. doi:10.1016/j.jtemb.2015.05.006
Moreira R, Martins AD, Alves MG, de Lourdes Pereira M, Oliveira PF. A Comprehensive Review of the Impact of Chromium Picolinate on Testicular Steroidogenesis and Antioxidant Balance. Antioxidants (Basel). 2023;12(8):1572. doi:10.3390/antiox12081572
Zha LY, Wang MQ, Xu ZR, Gu LY. Efficacy of chromium(III) supplementation on growth, body composition, serum parameters, and tissue chromium in rats. Biol Trace Elem Res. 2007;119(1):42-50. doi:10.1007/s12011-007-0042-8
Kostić S, Tasić I, Stojanović N, et al. Impact of Obesity on Target Organ Damage in Patients with Metabolic Syndrome. Diagnostics (Basel). 2024;14(14):1569. doi:10.3390/diagnostics14141569
Barbato JE, Zuckerbraun BS, Overhaus M, Raman KG, Tzeng E. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome. Am J Physiol Heart Circ Physiol. 2005;289(1):H228-36. doi:10.1152/ajpheart.00982.2004
Kostenko V, Akimov O, Gutnik O, et al. Modulation of redox-sensitive transcription factors with polyphenols as pathogenetically grounded approach in therapy of systemic inflammatory response. Heliyon. 2023;9(5):e15551. doi:10.1016/j.heliyon.2023.e15551
Kim B, Zhao W, Tang SY, et al. Endothelial lipid droplets suppress eNOS to link high fat consumption to blood pressure elevation. J Clin Invest. 2023;133(24):e173160. doi:10.1172/JCI173160
Bortolotti M, Polito L, Battelli MG, Bolognesi A. Xanthine oxidoreductase: One enzyme for multiple physiological tasks. Redox Biol. 2021;41:101882. doi:10.1016/j.redox.2021.101882
Lubawy M, Formanowicz D. High-Fructose Diet-Induced Hyperuricemia Accompanying Metabolic Syndrome-Mechanisms and Dietary Therapy Proposals. Int J Environ Res Public Health. 2023;20(4):3596. doi:10.3390/ijerph20043596
Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. Int J Mol Sci. 2021;22(17):9221. doi:10.3390/ijms22179221
Engin A. Endothelial Dysfunction in Obesity and Therapeutic Targets. Adv Exp Med Biol. 2024;1460:489-538. doi:10.1007/978-3-031-63657-8_17
Berenyiova A, Cebova M, Aydemir BG, Golas S, Majzunova M, Cacanyiova S. Vasoactive Effects of Chronic Treatment with Fructose and Slow-Releasing H2S Donor GYY-4137 in Spontaneously Hypertensive Rats: The Role of Nitroso and Sulfide Signalization. Int J Mol Sci. 2022;23(16):9215. doi:10.3390/ijms23169215
Smimmo M, Casale V, Casillo GM, et al. Hydrogen sulfide dysfunction in metabolic syndrome-associated vascular complications involves cGMP regulation through soluble guanylyl cyclase persulfidation. Biomed Pharmacother. 2024;174:116466. doi:10.1016/j.biopha.2024.116466
Bełtowski J, Wiórkowski K. Role of Hydrogen Sulfide and Polysulfides in the Regulation of Lipolysis in the Adipose Tissue: Possible Implications for the Pathogenesis of Metabolic Syndrome. Int J Mol Sci. 2022;23(3):1346. doi:10.3390/ijms23031346
Andrés CMC, Pérez de la Lastra JM, Andrés Juan C, Plou FJ, Pérez-Lebeña E. Chemistry of Hydrogen Sulfide-Pathological and Physiological Functions in Mammalian Cells. Cells. 2023;12(23):2684. doi:10.3390/cells12232684
Shi L, Liu B, Zhang X, et al. Cloning of Nitrate Reductase and Nitrite Reductase Genes and Their Functional Analysis in Regulating Cr(VI) Reduction in Ectomycorrhizal Fungus Pisolithus sp.1. Front Microbiol. 2022;13:926748. doi:10.3389/fmicb.2022.926748
Georgaki MN, Tsokkou S, Keramas A, Papamitsou T, Karachrysafi S, Kazakis N. Chromium supplementation and type 2 diabetes mellitus: an extensive systematic review. Environ Geochem Health. 2024;46(12):515. doi:10.1007/s10653-024-02297-5
Singh V, Singh N, Verma M, et al. Hexavalent-Chromium-Induced Oxidative Stress and the Protective Role of Antioxidants against Cellular Toxicity. Antioxidants (Basel). 2022;11(12):2375. doi:10.3390/antiox11122375
Imanparast F, Mashayekhi FJ, Kamankesh F, Rafiei F, Mohaghegh P, Alimoradian A. Improving the endothelial dysfunction in type 2 diabetes with chromium and vitamin D3 by reducing homocysteine and oxidative stress: A randomized placebo-controlled trial. J Trace Elem Med Biol. 2020;62:126639. doi:10.1016/j.jtemb.2020.126639
Bansal A, Mostafa MM, Kooi C, et al. Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells. J Biol Chem. 2022;298(4):101747. doi:10.1016/j.jbc.2022.101747
Wang YQ, Yao MH. Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK. J Nutr Biochem. 2009;20(12):982-91. doi:10.1016/j.jnutbio.2008.09.002
Murphy B, Bhattacharya R, Mukherjee P. Hydrogen sulfide signaling in mitochondria and disease. FASEB J. 2019;33(12):13098-13125. doi:10.1096/fj.201901304R
Soni P, Paswan S, Paul BD, Thomas B. Intersection of H2S and Nrf2 signaling: Therapeutic opportunities for neurodegenerative diseases. Neurotherapeutics. 2025;22(6):e00627. doi:10.1016/j.neurot.2025.e00627
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
